New Treatment Targets Resistant Hypertension
CHATTANOOGA, Tenn. (WDEF) - The FDA has approved Baxdrostat, the first aldosterone synthase inhibitor, as an add-on treatment for adults with hypertension that remains uncontrolled despite standard medications. The drug works…